Sox9 signaling in lung adenocarcinoma

肺腺癌中的 Sox9 信号传导

• 批准号: 8798984
• 负责人: Sharon R. Pine
• 金额: $ 32.46万
• 依托单位: RBHS -CANCER INSTITUTE OF NEW JERSEY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-19 至 2019-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8798984
• 关键词: Accounting; Adenocarcinoma Cell; Adult; Automobile Driving; Binding; Binding Sites; Biological Assay; Bypass; Cancer cell line; Cell Line; Cessation of life; Cisplatin; Clustered Regularly Interspaced Short Palindromic Repeats; Data; Development; Developmental Gene; Doxycycline; E-Cadherin; Embryo; Embryonic Development; Epidermal Growth Factor Receptor; Epithelial Cells; Epithelium; Event; Gene Targeting; Genes; Genetic; Goals; Growth; Guide RNA; Human; Human Development; In Vitro; Knock-out; Laboratories; Lead; Lung; Lung Adenocarcinoma; Lung Adenoma; Lung Neoplasms; Malignant Neoplasms; Malignant neoplasm of lung; Mediating; Mediator of activation protein; Mesenchymal; Molecular; Morphogenesis; Mus; Mutation; NF-kappa B; Nature; Oncogenes; Oncogenic; Pathway interactions; Patients; Phenotype; Play; Polyadenylation; Regulation; Reporting; Repression; Resistance; Role; Signal Pathway; Signal Transduction; Structure of parenchyma of lung; System; Technology; Testing; Therapeutic; Toxic effect; Transcriptional Regulation; Translating; Xeno; Xenograft procedure; addiction; cancer therapy; carcinogenesis; cell motility; chromatin immunoprecipitation; disorder control; improved; in vivo; loss of function; lung carcinogenesis; lung tumorigenesis; man; mouse model; mutant; notch protein; novel; novel therapeutics; overexpression; p65; promoter; public health relevance; transcription factor; translational approach; tumor; tumor progression; tumor xenograft

DESCRIPTION (provided by applicant): Tumors frequently enlist developmental genes to translate oncogenic signals into drivers of tumor progression. To gain a better understanding of the molecular mechanisms behind lung carcinogenesis and progression, we are focusing on the potential role of Sox9, a transcription factor required for human development. We found that Sox9 is barely expressed in normal lung tissue, but is overexpressed in primary human and murine lung tumors as well as lung cancer cell lines. We determined that Sox9 is not only a direct target gene of Notch1 signaling, but it is also a key mediator of Notch1-induced mesenchymal-like cellular morphological changes, E- cadherin repression, cell motility, and invasion in lung cancer. Our studies suggest that Sox9 is downstream of other oncogenic pathways. We propose that Sox9 is a terminal hub for convergence of upstream oncogenic signals, and plays a central role in mediating their contribution to lung tumorigenesis and progression. Therefore, targeting Sox9 expression could alleviate the resistance often invoked by redundant oncogenic pathways during treatment with targeted therapies. The overall goals of this proposal are to validate the pathways regulating Sox9 expression and mediating Sox9's role in the induction of cell motility and invasion. We will test the function of Sox9 during murine lun carcinogenesis. Using patient-derived lung tumor xenografts and a validated platform to target Sox9 in vivo, we will test if Sox9 repression has anti-tumor activity. This study will help in understanding the regulation of lung tumor progression by a novel embryonic developmental gene and develop a strategy for potentially circumventing therapeutic resistance.

描述（由申请人提供）：肿瘤经常利用发育基因将致癌信号转化为肿瘤进展的驱动因素。为了更好地了解肺癌发生和发展背后的分子机制，我们正在关注人类发育所需的转录因子Sox 9的潜在作用。我们发现Sox 9在正常肺组织中几乎不表达，但在原发性人类和小鼠肺肿瘤以及肺癌细胞系中过表达。我们确定Sox 9不仅是Notch 1信号传导的直接靶基因，而且它也是Notch 1诱导的间充质样细胞形态学变化、E-钙粘蛋白抑制、细胞运动和肺癌侵袭的关键介质。我们的研究表明，Sox 9是其他致癌途径的下游。我们认为Sox 9是上游致癌信号汇聚的终端枢纽，并在介导它们对肺肿瘤发生和进展的贡献中起着核心作用。因此，靶向Sox 9表达可以减轻在靶向治疗期间经常由冗余致癌途径引起的抗性。该提案的总体目标是验证调节Sox 9表达和介导Sox 9在诱导细胞运动和侵袭中的作用的途径。我们将测试Sox 9在小鼠肺癌发生过程中的功能。使用患者来源的肺肿瘤异种移植物和经验证的体内靶向Sox 9的平台，我们将测试Sox 9抑制是否具有抗肿瘤活性。这项研究将有助于了解一种新的胚胎发育基因对肺肿瘤进展的调控，并开发出一种潜在的规避治疗耐药性的策略。